Literature DB >> 362123

Pulmonary hemorrhage in systemic lupus erythematosus.

J W Eagen, V A Memoli, J L Roberts, G R Matthew, M M Schwartz, E J Lewis.   

Abstract

The clinicopathological features of four patients with systemic lupus erythematosus and pulmonary hemorrhage are described. Our study confirms that pulmonary hemorrhage may be a dominant clinical expression of lung involvement in this disease. Its clinical manifestations are usually quite characteristic. However, hemoptysis may be absent. Radiographically, bilateral alveolar infiltrates resembling pulmonary edema or infection may be seen. Pulmonary hemorrhage was a major contributing factor to the death of three of our patients. The possible pathogenetic mechanisms responsible for pulmonary hemorrhage in our patients and other patients previously recorded in the literature are reviewed. Evidence supporting an immune complex pathogenesis is presented. Our immunopathological and ultrastructural studies demonstrate deposition of immune aggregates in the lungs in the alveolar septa, large blood vessels, and bronchioles in a manner similar to that which has been observed in the experimental serum sickness model of immune complex mediated pulmonary injury. The histological abnormalities, although nonspecific, are consistent with this interpretation, and collectively show diffuse alveolar lining cell and endothelial cell injury. However, an immune complex pathogenesis may not completely explain the occurrence of pulmonary hemorrhage in SLE. Other factors, including bleeding disorders, pulmonary infection, oxygen toxicity, and the "shock lung" syndrome, may also have contributed to lung hemorrhage in some of these patients.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 362123     DOI: 10.1097/00005792-197811000-00005

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  21 in total

Review 1.  Small vessel vasculitis of the lung.

Authors:  M I Schwarz; K K Brown
Journal:  Thorax       Date:  2000-06       Impact factor: 9.139

2.  MicroRNA-127 inhibits lung inflammation by targeting IgG Fcγ receptor I.

Authors:  Ting Xie; Jiurong Liang; Ningshan Liu; Qingguo Wang; Yuhang Li; Paul W Noble; Dianhua Jiang
Journal:  J Immunol       Date:  2012-01-27       Impact factor: 5.422

Review 3.  Utility of serologic testing in the diagnosis of noninfectious pulmonary disorders.

Authors:  R H White; J A Golden
Journal:  Clin Rev Allergy       Date:  1990 Summer-Fall

4.  Playing saxophone induced diffuse alveolar hemorrhage: a case report.

Authors:  Y-C Ko; M-P Dai; C-C Ou
Journal:  Ir J Med Sci       Date:  2009-06-30       Impact factor: 1.568

5.  Diffuse alveolar hemorrhage in Colombian patients with systemic lupus erythematosus.

Authors:  Carlos Cañas; Gabriel J Tobón; Marcela Granados; Liliana Fernández
Journal:  Clin Rheumatol       Date:  2007-03-22       Impact factor: 2.980

6.  Histiocytic necrotising lymphadenitis in systemic lupus erythematosus.

Authors:  M D Litwin; B Kirkham; D R Henderson; S C Milazzo
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

Review 7.  The ultrastructure of human fibrosing alveolitis.

Authors:  J J Coalson
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982

8.  Immunohistological study of human lungs by immunoperoxidase technique.

Authors:  B Fox; S Shousha; K R James; G C Miller
Journal:  J Clin Pathol       Date:  1982-02       Impact factor: 3.411

Review 9.  Pulmonary rehabilitation in idiopathic pulmonary fibrosis: a call for continued investigation.

Authors:  Jeffrey J Swigris; Kevin K Brown; Barry J Make; Frederick S Wamboldt
Journal:  Respir Med       Date:  2008-10-10       Impact factor: 3.415

10.  Immune complex mediated lung haemorrhage and nephritis--successful treatment with plasma exchange, haemodialysis and immunosuppressive drug therapy.

Authors:  P J Drew; A C Newland; F P Marsh
Journal:  Postgrad Med J       Date:  1984-01       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.